Latest Laval Stories
- Angelini Labopharm Joint Venture to Launch OLEPTRO(TM) in Third Quarter of This Year - LAVAL, QC, May 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today reported its financial results for the first quarter 2010.
Canadian researchers have discovered a previously hidden channel to attack leukemia and other cancer cells, according to a new study published in the Journal of Biological Chemistry.
- Company Preparing for Q3 2010 U.S. Launch of OLEPTRO(TM) - LAVAL, QC, Feb. 25 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2009.
The southern limit of permanently frozen ground, or permafrost, is now 130 kilometers further north than it was 50 years ago in the James Bay region.
LAVAL, QC and PRINCETON, NJ, Feb. 3 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S.
Even after regaining normal walking speed, traumatic brain injury (TBI) victims have not necessarily recovered all their locomotor functions, according to a study supervised by UniversitÃ© Laval's Bradford McFadyen and recently published in Archives of Physical Medicine and Rehabilitation.
The results of a recent study published in PNAS question the long-term effects of transplanted cells in the brains of patients suffering from Huntington's disease.
A research team including Serge Rivest of University Laval's Faculty of Medicine has demonstrated the existence of a type of cells that limits brain damage after a stroke.
Women who smoke during pregnancy risk delivering aggressive kids according to a new Canada-Netherlands study published in the journal Development and Psychopathology.
Wildlife satellite studies could lead to a radical re-thinking about how the snowy owl fits into the Northern ecosystem.